drugset / Trial / NCT02697188
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Phase 2
Completed
12 enrolled
Clarus Therapeutics, Inc.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · collab
Non-randomizedCrossoverOpen-labelTreatment
Summary
Determine the serum pharmacokinetic profile for two oral formulations of T-esters (one TE and one TU) administered once -(QD) and twice-daily (BID) to hypogonadal men.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Testosterone Enanthate | Small molecule | 400 mg | Oral |
| Subject | Testosterone Undecanoate | Small molecule | 100 mg | Oral |
| Subject | Testosterone Undecanoate | Small molecule | 200 mg | Oral |